4//SEC Filing
Maynard Ryan D 4
Accession 0001415889-24-003404
CIK 0001346830other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:15 PM ET
Size
5.1 KB
Accession
0001415889-24-003404
Insider Transaction Report
Form 4
Maynard Ryan D
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-02-08$0.53/sh−5,488$2,909→ 8,012 total
Footnotes (1)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on September 14, 2023 accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001363984
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:15 PM ET
- Size
- 5.1 KB